Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 893

Results For "IT"

10255 News Found

S.M.A.R.T. Radianz Vascular Stent System approved for transradial use in the U.S.
Medical Device | March 13, 2022

S.M.A.R.T. Radianz Vascular Stent System approved for transradial use in the U.S.

It signals Cordis' renewed investment in innovation


Terran Biosciences acquires Concert’s CNS therapeutics portfolio
News | March 12, 2022

Terran Biosciences acquires Concert’s CNS therapeutics portfolio

These new chemical entities are covered by composition of matter patent applications. Financial terms of the deal were not disclosed


Study shows Pfizer vaccine moderately effective against Omicron for children 5-15
News | March 12, 2022

Study shows Pfizer vaccine moderately effective against Omicron for children 5-15

The study looked at 1,364 children in Arizona, Florida, Texas, and Utah who submitted weekly nasal swabs and surveys from July 2021 through February 2022, regardless of whether they had symptoms


Govt earmarks Rs 500 crore for pharma clusters and MSMEs
Policy | March 12, 2022

Govt earmarks Rs 500 crore for pharma clusters and MSMEs

Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers releases guidelines for the scheme


China approves BeiGene’s tislelizumab
Drug Approval | March 12, 2022

China approves BeiGene’s tislelizumab

Tislelizumab is now approved for seven indications in China


Moderna begins Phase 2 study of Omicron-specific bivalent booster
Biotech | March 11, 2022

Moderna begins Phase 2 study of Omicron-specific bivalent booster

Moderna's Omicron-specific bivalent booster candidate combines its Omicron-specific booster candidate with its Covid-19 vaccine


First-in-human trial in US for Gan & Lee type 2 diabetes drug
Biotech | March 11, 2022

First-in-human trial in US for Gan & Lee type 2 diabetes drug

The primary objective of this Phase 1 study is to investigate the safety and tolerability of GZR18 in healthy volunteers


Strides receives USFDA approval for Colchicine tablets
Drug Approval | March 11, 2022

Strides receives USFDA approval for Colchicine tablets

Colchicine tablets are used for the treatment and prevention of gout. It reduces inflammation which causes pain, swelling and other symptoms of gout


USFDA approves Lupin’s Vigabatrin oral solution
Drug Approval | March 11, 2022

USFDA approves Lupin’s Vigabatrin oral solution

The product will be manufactured at Lupin’s facility in Goa, India


AbbVie and Gedeon Richter to collaborate on neuropsychiatric diseases
Biotech | March 11, 2022

AbbVie and Gedeon Richter to collaborate on neuropsychiatric diseases

Agreement builds on 15 years of successful collaboration between AbbVie and Richter, including globally launched cariprazine products